Topotecan in mantle cell lymphoma - A 21 day continuous infusion regimen may have advantages over intermittent therapy.

Samankaltaisia teoksia

• Repeated Infusions of Brexucabtagene-autoleucel in Relapsed/Refractory Mantle Cell Lymphoma
  Tekijä: Enver Aydilek, et al.
  Julkaistu: (2023-09-01)
• Weekly topotecan regimen in the treatment of recurrent ovarian cancer: search for alternatives to upholding the quality of life
  Tekijä: E. G. Novikova, et al.
  Julkaistu: (2014-08-01)
• The role of topotecan in cancer ginecology treatment
  Tekijä: A. G. Kedrova, et al.
  Julkaistu: (2017-02-01)
• Recurrent ovarian cancer: prolongation of the platinum-free interval with the use of a weekly treatment regimen of hycamtin (topotecan)
  Tekijä: E. G. Novikova, et al.
  Julkaistu: (2014-07-01)
• The Lipophilic Purine Nucleoside—Tdp1 Inhibitor—Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo
  Tekijä: Irina A. Chernyshova, et al.
  Julkaistu: (2022-12-01)